Lates News

Biotechnology company Dyadic International (DYAI) fell by 2.3%. The company announced that it is expected to achieve a milestone revenue of $500,000 as it transitions to a commercialized biotechnology company. Recently, the company completed a $5.3 million equity financing and is currently focused on developing scalable protein production technology.